USPTO serial 88716290
IMNEWRUN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- DINALLO, KEVIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IMNEWRUN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do, KR
SUWON-SI, GYEONGGI-DO, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lenny R. Jiang
Lenny R. Jiang Paratus Law Group, PLLC1765 Greensboro Station PlaceSuite 320Tysons Corner, VA 22102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated toiletry preparations; Cosmetic preparations | ACTIVE | — |
| 005 | Chemico-pharmaceutical preparations for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders; Medicated shampoos; ; Drugs for medical purposes for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders; Chemical preparations for medical purposes for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders; Enzyme preparations for medical purposes for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders; Medicated serums for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders; Vaccines; Nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, brain cancer, neurodegenerative disease, genetic disorders, neuromuscular disease, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, muscle disorders, and immune related disorders | ACTIVE | — |
| 010 | Measuring instruments for medical purposes for measuring blood pressure, detection of antibody and clinical research; Diagnostic apparatus and instruments for medical purposes for the detection of cancer, Alzheimer's disease, viral infections and bacterial infections; Biomaterials for dermatology, namely, artificial biomaterials for augmentation of bone and tissue for medical purposes; Medical apparatus and instruments for use in general surgery; Orthopedic articles, namely, orthopedic implants made of artificial materials | ACTIVE | — |
| 042 | Scientific research in the fields of biomedicine; Pharmaceutical products development; Medical laboratory services; Medicine research; Scientific research in the fields of medicine, health and pharmacology; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Imnewrun Biosciences, Inc.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by Imnewrun Biosciences, Inc.
- Other trademarks owned by Imnewrun Biosciences, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named IMNEWRUN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 16, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 21, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 20, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 8, 2021 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Apr 8, 2021 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Apr 2, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2021 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 1, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 26, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2021 | IUAF | USE AMENDMENT FILED | — |
| Mar 17, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 22, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2019 | NWAP | NEW APPLICATION ENTERED | — |